Actively Recruiting

Phase 3
Age: 18Years - 90Years
All Genders
NCT07197944

Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS

Led by Zealand Pharma · Updated on 2026-04-20

90

Participants Needed

23

Research Sites

315 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of the present Phase 3 trial is to confirm the efficacy and safety of glepaglutide 10 mg twice weekly in a patient population with SBS-IF and generate additional long-term safety data. Glepaglutide is the International Nonproprietary Name and United States Adopted Name (USAN) for ZP1848.

CONDITIONS

Official Title

Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS

Who Can Participate

Age: 18Years - 90Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Signed informed consent
  • Age 18 to 90 years
  • Diagnosis of short bowel syndrome with small bowel length less than 200 cm in continuity
  • Stable need for parenteral support at least 3 days per week
  • No planned restorative surgery during the trial period
  • Presence of a stoma or colon in continuity
Not Eligible

You will not qualify if you...

  • More than 2 hospitalizations related to short bowel syndrome or parenteral support within 6 months before screening
  • Poorly controlled inflammatory bowel disease that is moderately or severely active or presence of fistula interfering with trial measurements
  • History of colorectal cancer or other cancers unless disease-free for at least 5 years, except certain treated skin or cervical cancers
  • Ongoing bowel obstruction
  • Body mass index (BMI) below 18.5 kg/m2

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 23 locations

1

Washington University Center for Advanced Medicine

St Louis, Missouri, United States, 63110

Actively Recruiting

2

Lied Transplant Center at Nebraska Medical Center

Omaha, Nebraska, United States, 68105

Actively Recruiting

3

New York Presbyterian Hospital-Columbia University Medical Center

New York, New York, United States, 10032

Not Yet Recruiting

4

Vanderbilt University Medical Center

Nashville, Tennessee, United States, 37232

Actively Recruiting

5

Universitätsklinikum AKH Wien

Vienna, State of Vienna, Austria, 1090

Actively Recruiting

6

Rigshospitalet-Blegdamsvej 9

Copenhagen, Denmark, 2100

Actively Recruiting

7

AP-HP - Hôpital Beaujon

Clichy, France, 92118

Actively Recruiting

8

Universitätsmedizin Rostock

Rostock, Mecklenburg-Vorpommern, Germany, 18057

Actively Recruiting

9

Eugastro Klinische Studien GmbH

Leipzig, Saxony, Germany, 4103

Actively Recruiting

10

Charité - Universitätsmedizin Berlin

Berlin, Germany, 10117

Actively Recruiting

11

Universitätsklinikum Bonn

Bonn, Germany, 53127

Actively Recruiting

12

Asklepios Klinik St. Georg

Hamburg, Germany

Actively Recruiting

13

Semmelweis Egyetem - Sebészeti, Transzplantációs és Gasztroenterológiai Klinika

Budapest, Hungary, 1082

Actively Recruiting

14

Fondazione Policlinico Universitario A. Gemelli IRCCS - PPDS

Rome, Lazio, Italy, 00136

Actively Recruiting

15

Radboud Universitair Medisch Centrum

Nijmegen, Gelderland, Netherlands, 6525 GA

Actively Recruiting

16

Oslo Universitetssykehus HF, Ullevål

Oslo, Norway, 0450

Actively Recruiting

17

Wojewodzki Specjalistyczny Szpital im. M. Pirogowa w Lodzi

Lodz, Lódzkie, Poland, 90-531

Actively Recruiting

18

Samodzielny Publiczny Szpitala Kliniczny im. Prof. Witolda Orlowskiego Centrum Medycznego Kształcenia Podyplomowego

Warsaw, Poland, 00-416

Actively Recruiting

19

Hospital General Universitario Gregorio Marañon

Madrid, Spain, 28007

Actively Recruiting

20

Hospital Universitario 12 de Octubre

Madrid, Spain, 28041

Actively Recruiting

21

Hospital Universitario Virgen del Rocio - PPDS

Seville, Spain, 41013

Actively Recruiting

22

Sahlgrenska Universitets sjukhuset

Gothenburg, Sweden, 413 46

Actively Recruiting

23

Karolinska Universitetssjukhuset Solna

Solna, Sweden, 171 64

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here